Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

NVIV | InVivo Therapeutics Holdings Corp

Index- P/E- EPS (ttm)-4.43 Insider Own10.74% Shs Outstand3.11M Perf Week-0.88%
Market Cap3.48M Forward P/E- EPS next Y-547.50 Insider Trans0.00% Shs Float2.77M Perf Month-7.44%
Income-9.38M PEG- EPS next Q-225.00 Inst Own3.13% Short Float / Ratio0.52% / 0.93 Perf Quarter-17.04%
Sales0.00M P/S- EPS this Y-1244.44% Inst Trans57.69% Short Interest0.01M Perf Half Y9.80%
Book/sh3.73 P/B0.30 EPS next Y39.67% ROA-63.83% Target Price180.00 Perf Year-73.89%
Cash/sh3.45 P/C0.32 EPS next 5Y- ROE-76.95% 52W Range0.81 - 7.98 Perf YTD-52.34%
Dividend- P/FCF- EPS past 5Y78.59% ROI-79.15% 52W High-85.96% Beta0.84
Dividend %- Quick Ratio9.14 Sales past 5Y0.00% Gross Margin- 52W Low38.96% ATR0.06
Employees6 Current Ratio9.14 Sales Q/Q- Oper. Margin0.00% RSI (14)43.34 Volatility7.59% 4.64%
OptionableNo Debt/Eq0.06 EPS Q/Q68.27% Profit Margin- Rel Volume2.19 Prev Close1.16
ShortableYes LT Debt/Eq0.02 Earnings- Payout- Avg Volume15.38K Price1.12
Recom1.00 SMA20-3.30% SMA50-8.76% SMA200-25.29% Volume9,227 Change-3.45%
Date Action Analyst Rating Change Price Target Change
Jul-31-17Downgrade Raymond James Outperform → Mkt Perform
May-05-17Downgrade Raymond James Strong Buy → Outperform
Jul-21-16Initiated Ladenburg Thalmann Buy
Jul-07-16Initiated Raymond James Strong Buy $13
Mar-09-23 12:28PM
Oct-11-22 04:01PM
Oct-07-22 08:00AM
Sep-09-22 08:00AM
08:30AM Loading…
Jul-13-22 08:30AM
Jun-08-22 08:30AM
Jun-02-22 08:30AM
Apr-18-22 08:54AM
Apr-14-22 04:49PM
Jan-06-22 08:00AM
Sep-09-21 08:00AM
Sep-08-21 08:00AM
Jul-19-21 06:13AM
09:13AM Loading…
Jul-13-21 09:13AM
Jul-06-21 08:05AM
Jun-13-21 11:22PM
Mar-12-21 08:00AM
Mar-05-21 08:00AM
Feb-16-21 08:00AM
Jan-18-21 05:47AM
Oct-26-20 04:15PM
Oct-22-20 09:15AM
Sep-11-20 08:30AM
Apr-17-20 12:19PM
Apr-15-20 07:30PM
Mar-11-20 04:27PM
Mar-06-20 09:15AM
04:30PM Loading…
Feb-03-20 04:30PM
Nov-22-19 04:30PM
Nov-21-19 08:00AM
Nov-18-19 08:15AM
Nov-12-19 08:00AM
Oct-29-19 10:51AM
Oct-22-19 08:00AM
Jul-16-19 08:00AM
Jul-12-19 08:00AM
Jun-14-19 08:00AM
May-29-19 02:54PM
Apr-17-19 08:00AM
Apr-01-19 08:15AM
Jan-14-19 08:00AM
Nov-29-18 08:00AM
Nov-19-18 09:00AM
Nov-08-18 06:55PM
Oct-02-18 08:00AM
Oct-01-18 08:00AM
Sep-28-18 08:05AM
Aug-28-18 08:00AM
Aug-07-18 07:42PM
Jun-25-18 04:05PM
Jun-21-18 09:00AM
May-24-18 10:35AM
May-07-18 06:44PM
Apr-18-18 08:20AM
Apr-09-18 08:00AM
Mar-19-18 08:00AM
Mar-12-18 08:35AM
Mar-09-18 10:34AM
Mar-08-18 08:00AM
Feb-05-18 08:00AM
Jan-29-18 07:00AM
Jan-26-18 08:00AM
Jan-03-18 08:00AM
Dec-18-17 08:00AM
Nov-06-17 08:00AM
Oct-30-17 06:03PM
Oct-11-17 10:14AM
Oct-10-17 08:00AM
Sep-20-17 08:00AM
Sep-05-17 08:00AM
Aug-29-17 05:59PM
Aug-28-17 04:30PM
Aug-10-17 09:00AM
Aug-09-17 11:37PM
Aug-08-17 06:00PM
Aug-01-17 08:00AM
Jul-31-17 12:46PM
Jul-12-17 08:00AM
Jul-11-17 08:00AM
Jul-10-17 08:00AM
Jun-29-17 08:00AM
Jun-28-17 09:45AM
Jun-27-17 08:00AM
Jun-20-17 08:00AM
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert S. Langer, Jr. in January 2005 and is headquartered in Cambridge, MA.